INTRODUCTION {#s1}
============

Glioma is the most common primary intracranial tumor account for about 40% of central nervous system tumors and 70% of malignant brain tumors \[[@R1]\], Whose treatment protocols are mostly based on surgical treatment, radiation therapy or temozolomide adjuvant chemotherapy \[[@R2]\]. However, the primary treatment of glioma is microscopic surgical resection, which must be maximally remove the tumor tissues and preserving normal nerve function. But it is a challenge to resect total tumor lesion due to the ambiguous boundary between tumor and normal tissue with glioma invasive growth \[[@R3]--[@R4]\]. Thus, the precise tumor localization and boundary identification are required to improve surgical strategies. The real-time images and position marks properties of intraoperative ultrasound (IOUS) were extensively used in tumor location, residue monitoring, guidance of aspiration biopsy and imaging blood flow of intracranial glioma \[[@R5]--[@R6]\], which is easy to operate and can be applied repeatedly. In comparison, intraoperative magnetic resonance imaging (iMRI) and navigational positioning system are limited by the expensive facility and need to avoid bias of brain transformation or shifting after skull opening in detecting intracranial glioma remnants\[[@R7]--[@R8]\]. In recent years, the clinical application of detection equipment for tumor residual may decrease the rate of malignant degeneration and prolong the median survival time and progression-free interval through the radical excision \[[@R9]\]. However, the diagnosis value of IOUS to detect the intracranial tumor removal is remains controversial due to the absence of cases and long-term follow-up data. And a point of ongoing discussion of iMRI, PET and navigational positioning system are superior to IOUS with insufficient data supporting. Thus, we performed this systematical review and meta-analysis to investigate the diagnostic values of IOUS in glioma operation.

RESULTS {#s2}
=======

Selection and characteristics of studies {#s2_1}
----------------------------------------

A total of 542 articles were yielded in primary literature search, which included 147 records identified from PubMed, 36 records from Embase, 90 records from Web of Science, 106 records from China National Knowledge Infrastructure (CNKI), 88 records from Wanfang and 75 records from Weipu. After screening duplicate and unrelated topic, 37 articles were identified to further read by retrieving the full text. Finally, on the basis of above inclusion criteria, 14 articles were included with 1946 samples \[[@R10]--[@R14], [@R15]--[@R23]\]. The literature screening process and results are given in Figure [1](#F1){ref-type="fig"}.

![Flow diagram of studies selection process](oncotarget-08-73105-g001){#F1}

The diagnostic accuracy of ultrasound for detecting glioma residual when the surgeons were considered excised completely should evaluate in all included studies. We know a patient could take more than one biopsy samples, only a few studies (*n* = 3) take patients as their object of study. When the patients and nidus on biopsy were both presented, we employed the latter, because the ultrasound results were one-to-one correspondence to every focus. We extracted the author, country, year of publication, mean age, sample size from the eligible articles, which were published between 1996 and 2016. The basic characteristics of the included studies are given in Table [1](#T1){ref-type="table"}.

###### Characteristics of the included studies in the meta-analysis

  No.   Author    Year   Region   Mean age(y)     Sample size   Study design   Study population   TP    FP   FN   TN
  ----- --------- ------ -------- --------------- ------------- -------------- ------------------ ----- ---- ---- -----
  1     He        2012   China    35.6 ± 8.2      38            Prospective    Single center      5     4    5    24
  2     Qiu       2015   China    45.1 ± 13.1     173           Prospective    Single center      20    10   13   130
  3     Yang      2014   China    43.47 ± 13.83   83            Prospective    Single center      13    10   8    52
  4     Wang      2009   China    39.0 ± 10.9     150           Prospective    Single center      48    7    21   74
  5     Tian      2009   China    41              189           Prospective    Single center      101   19   25   44
  6     Guo       2011   China    41.6            373           Prospective    Single center      48    5    36   284
  7     Chen      2007   China    39.6            216           Prospective    Single center      23    3    12   178
  8     Liu       2009   China    22--68          80            Prospective    Single center      44    11   6    19
  9     Woydt     1996   German   45.8            78            Prospective    Single center      47    6    6    19
  10    Becker    1999   German   45.6            31            Prospective    Single center      24    2    1    4
  11    Chacko    2003   India    38.2 ± 8.8      96            Prospective    Single center      66    13   2    15
  12    Venelin   2011   German   \-              11            Prospective    Single center      5     1    1    4
  13    Shu       2016   China    39.6 ± 6.8      360           Prospective    Single center      69    18   42   231
  14    Jan       2015   German   56              68            Prospective    Single center      12    1    37   18

Quality evaluation {#s2_2}
------------------

The summary of the quality assessment with regard to risk of bias and applicability concerns is shown in [Supplementary Figure 1](#SD1){ref-type="supplementary-material"} and [Supplementary Figure 2](#SD1){ref-type="supplementary-material"}. We scored the questions as "low", "high", or "unclear" to examine included studies. As we can see, 1 study in patient selection is treated as high concern for applicability concerns. In summary, the quality of included studies met requirements for meta-analysis.

Quantitative synthesis {#s2_3}
----------------------

The latest Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols were applied here. The study selection, data extraction, and risk of bias evaluation were performed by two authors independently to ensure the quality of this meta-analysis. Notable heterogeneity was observed on account of I^2^ = 89.21%, *P* \< 0.01 for sensitivity and I^2^ = 91.55%, *P* \< 0.01 for specificity. Therefore, a random effects model was adopted for this meta-analysis. We calculated the pooled sensitivity of 0.75 (95%CI: 0.62--0.84), pooled specificity of 0.88 (95%CI: 0.79--0.94). The overall positive likelihood ratios (PLR) and negative likelihood ratios (NLR) were 6.27 (95%CI: 3.76--10.47) and 0.29 (95%CI: 0.20--0.42), respectively. The diagnostic odds ratios (DOR) was 21.83 (95%CI: 14.20--33.55) (Figure [2](#F2){ref-type="fig"} and Figure [3](#F3){ref-type="fig"}). Based on the sensitivity and specificity, we generated an summary receiver operator characteristic (SROC). The area under the curve (AUC) of the SROC was 0.89 (95%CI: 0.85--0.91), which suggested that IOUS has a relatively high diagnostic value for detecting glioma residual (Figure [4](#F4){ref-type="fig"}). As showed on the Fagan plot, the prior probability was 20%, posterior probabilities of PLR and NLR were 61% and 7%, respectively (Figure [5](#F5){ref-type="fig"}). In general, IOUS demonstrated high diagnostic accuracy in detecting glioma residues during surgical operation.

![Forest plot of pooled sensitivity of intraoperative ultrasound for glioma residual](oncotarget-08-73105-g002){#F2}

![Forest plot of pooled specificity of intraoperative ultrasound for glioma residual](oncotarget-08-73105-g003){#F3}

![The SROC curve of intraoperative ultrasound for glioma residual](oncotarget-08-73105-g004){#F4}

![Fagan diagram evaluating the overall diagnostic value of intraoperative ultrasound for glioma residual](oncotarget-08-73105-g005){#F5}

Stratified analysis {#s2_4}
-------------------

In order to assess the impact of heterogeneity, we conducted subgroup analyses to further research the diagnostic power of IOUS in glioma residual resection. We suspected that study region, mean age, sample size and glioma grading could affect the pooled parameters of IOUS diagnosis evaluation. Further studies showed that parameters in mean age, sample size and region were no obvious difference between the pooled data, which suggesting those factors were not greatly impact on heterogeneity. However, the sensitivity of low-grade glioma reached a high accuracy (rose from 0.75 to 0.87). The meta-regression analysis revealed IOUS was more accurate for low-grade glioma than high-grade glioma to detect residual (AUC 0.93 vs. 0.83). But it limited to few samples, it will be more robust and credible with increased studies and standardized methodology. The detail parameters for each subgroup are summarized in Table [2](#T2){ref-type="table"}.

###### The pooled sensitivity, specificity, PLR, NLR and DOR, and their 95% CI for each subgroup

  Category             SEN(95% CI)           SPE(95% CI)           PLR(95% CI)             NLR(95% CI)           DOR(95% CI)                              AUC(95% CI)
  -------------------- --------------------- --------------------- ----------------------- --------------------- ---------------------------------------- ---------------------
  **Region**                                                                                                                                              
   Asian               0.73 \[0.63--0.8\]    0.89 \[0.78--0.94\]   6.43 \[3.56--11.62\]    0.30 \[0.23--0.40\]   21.23 \[[@R13].[@R20]--[@R34].[@R15]\]   0.86 \[0.83--0.89\]
   Europe              0.66 \[0.58--0.74\]   0.82 \[0.69--0.91\]   3.59 \[2.08--6.19\]     0.21 \[0.03--1.45\]   19.82 \[7.69--51.12\]                    0.88 \[0.84--0.89\]
  **Mean age(y)**                                                                                                                                         
   ≤ 41.6              0.73 \[0.60--0.83\]   0.91 \[0.78--0.96\]   7.68 \[3.47--16.99\]    0.30 \[0.21--3.87\]   25.44 \[13.52--47.87\]                   0.87 \[0.84--0.90\]
   \> 41.6             0.75 \[0.50--0.90\]   0.84 \[0.68--0.93\]   4.64 \[2.76--7.78\]     0.29 \[0.14--0.60\]   15.76 \[8.90--27.91\]                    0.87 \[0.83--0.90\]
  **Sample size**                                                                                                                                         
   ≤ 100               0.81 \[0.59--0.93\]   0.77 \[0.64--0.86\]   3.47 \[2.46--4.88\]     0.25 \[0.12--0.54\]   13.88 \[6.71--28.73\]                    0.84 \[0.81--0.87\]
   \> 100              0.66 \[0.58--0.73\]   0.94 \[0.86--0.97\]   10.54 \[5.06--21.95\]   0.36 \[0.30--0.44\]   29.15 \[15.14--56.15\]                   0.81 \[0.77--0.84\]
  **Glioma grading**                                                                                                                                      
   Low                 0.87 \[0.77--0.94\]   0.89 \[0.80--0.95\]   4.71 \[1.35--16.43\]    0.20 \[0.11--0.35\]   45.37 \[14.99--137.4\]                   0.93 \[0.91--0.96\]
   high                0.76 \[0.67--0.84\]   0.75 \[0.62--0.85\]   2.84 \[1.36--5.93\]     0.31 \[0.18--0.56\]   10.43 \[4.11--26.45\]                    0.83 \[0.80--0.85\]

Sensitivity analysis and publication bias {#s2_5}
-----------------------------------------

We performed sensitivity analysis by excluding individual study sequentially. There was no remarkable variation for pooled parameters (the detail data were not given), indicating the pooled estimations were stable. The Deek\'s plot were used to evaluate the publication, as the Figure [6](#F6){ref-type="fig"} indicates that was no significant publication bias exist (t = −1.03, *P* = 0.33).

![Deek\'s funnel plot to evaluate the publication bias](oncotarget-08-73105-g006){#F6}

DISCUSSION {#s3}
==========

Nowadays, more fully precise excision of glioma is a challenge for neurosurgeons, the large extent of tumor resection could influence the prognosis and quality of life for patients. Ultrasound is an old and common technology, but lack of sufficient evidence to prove that is a valid method tool at characterizing glioma residual. The high sensitivity and specificity (0.75 and 0.88) in this meta-analysis revealed that IOUS is a meritorious tool to distinguish glioma margins clearly in surgical excision, especially in low-grade glioma with larger AUC than high-grade glioma. Distinguished edema from irregular shape and infiltrating growth is probably hard for high-grade glioma, even ultrasound can display tumor areas at normal blood brain barriers \[[@R24]\].

An appropriate diagnostic method include accuracy, real-time, low price, and effectiveness. IOUS meets these requirements and can be performed multiple times \[[@R25]\]. According to Woydt\'s tumor residual norm \[[@R10]\], irregular hyperecho or annular strong echo stretches into the surrounding brain tissues of residual cavity with the thickness ≥ 5 mm as tumor residue. We used IOUS to detect glioma location, tumor size, the distance from cortex, surrounding blood supply and para-carcinoma tissues for identifying the extent of tumor removal. The results showed diagnostic odds ratio is 21.83 and the pooled PLRs are 6.27 and 0.29, which indicate the probability of tumor residues diagnosis compared with brain tissues is 6.27 times in case of hyperecho exceeds the cut-off value. On the contrary, the probability of definite case is 29% when it is below the cut-off value. IOUS has unique advantages, but it cannot fully replace other detection tools with the interference of ultrasonic pseudo morphism, bubbles, blood clot \[[@R26]\]. As we know, neuronavigation is more accurate for tumors less than 1 cm, but the application is restricted by brain deformation or shifting after skull opening \[[@R27]--[@R28]\]. So an integration of IOUS into neuronavigation could offer a combine image to determine the tumor boundary.

Now give some suggestion to avoid false positives by using proper operation and sufficient experience. (i) remove hemostasis material from the residual cavity before using ultrasound; (ii) using physiological saline to improve diagnostic accuracy; (iii) discern the echo size and position among tumor tissue, distinguish edema and colloid hyperplasia carefully; (iv) the hematoma and edema with clearer boundary presented stronger echo, but necrosis and cystic degeneration is hypoechoic. The examiner must be aware of ultrasound technology to define margins and assess the degree of resection in surgery.

In recent years, contrast enhanced ultrasound provides more anatomy and pathology information and offers clearly tumor boundary by new-type contrast agents appeared \[[@R29]\]. With the improvement of ultrasound technology, linear-array ultrasound has been offered to further resection in surgery operation. IOUS has become an indispensable tool to judge the degree of glioma resection, identify gliosis from gliomas and estimate tumor pathology classification \[[@R30]\].

In conclusion, this systematic review and meta-analysis was to evaluate the diagnostic features of intraoperative ultrasound, which has a significantly higher diagnosis accuracy. Current evidence suggests that IOUS may be a useful and non-invasive method for detecting glioma margin and allows safer removal.

MATERIALS AND METHODS {#s4}
=====================

Search protocol {#s4_1}
---------------

We conducted a literature search through following electronic databases: PubMed, Embase, Web of Science, CNKI, Wanfang and Weipu updated to May 5, 2017. Meanwhile, Google and Baidu engine were searched by comparing IOUS and pathological diagnostic criteria for treatment of glioma residues. Our research protocol consists of the detailed search strategy, screening criteria for titles, abstracts, and full-text articles. The search terms included "intraoperative ultrasound" or "ultrasonography" or "IOUS" and "intracranial glioma" or "glioma" and "residue" or "remnant". In order to find all potentially eligible articles, we searched the reference lists manually for relevant study. The Preferred Reporting Items for Systematic Reviews was used in this meta-analysis \[[@R31]\]. The checklist guidelines was shown in [Supplementary Table 1](#SD2){ref-type="supplementary-material"}.

Selection criteria {#s4_2}
------------------

The inclusion criteria were as follows: 1) all cases were performed by IOUS before harvesting pathological results; 2) the process of IOUS was evaluated; 3) raw data were sufficient to calculate true positive (TP), false positive (FP), false negative (FN) and true negative (TN); 4) abstract, review, conference paper and case report (less than 5 cases) were excluded; 5) no partial data or repetitive publication was permitted; 6) intracranial tumors were not admitted (except intracranial glioma), such as cavernous hemangioma, metastatic encephala, and radiation necrosis; 7) only human studies were included and the language was limited in English and Chinese.

Data extraction and quality assessment {#s4_3}
--------------------------------------

According to the above criteria, two authors independently filtered the unqualified studies by reading the titles and abstracts, and then scanned full texts of the remaining articles to find the eligible one. Duplicate records were deleted. In this process, any divergence was resolved through discussion. The extracted data included article serial number, title, the name of first author, country, year of publication, mean age and sample size. Moreover, specificity, sensitivity and TP/FP/FN/TN were extracted from each eligible article or could calculate relevant data from original article.

The selected articles quality were assessed by the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) \[[@R32]\], which included two fields of risk of bias and applicability. Each field consists of four items: patient selection, index text, reference standard, and flow & timing. Each item contains 17 sub-clauses as questions. We scored the questions as "low", "high", or "unclear" to examine diagnostic studies.

Statistical analysis {#s4_4}
--------------------

The pooled sensitivity, specificity, diagnostic odds ratios (DOR), positive likelihood ratios (PLR), negative likelihood ratios (NLR), area under the curve (AUC) and the corresponding 95% confidence intervals (CIs) were calculated by bivariate regression model on Stata 12.0 software and Review manager 5.3. The summary receiver operator characteristic (SROC) curves were plotted for graphical assessment. Threshold effect from different diagnostic cutoff values was tested by Spearman correlation analysis. Heterogeneity was detected via *Q* test and I^2^ statistic, with I^2^ \> 50% and *P* \< 0.05 indicating the presence of heterogeneity \[[@R33]--[@R34]\]. If heterogeneity existed, a random effects model was performed, otherwise a fixed effects model was used. And subgroup analysis was conducted to dissect the heterogeneity. Publication bias was evaluated visually by using Deek\'s funnel plots; the likelihood ratio, prior probability and posterior probability were tested by Fagan plot \[[@R35]\]. The *P* \< 0.05 was considered as statistical significance.
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